These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3620119)

  • 1. The possible role of Limulus-amebocyte-lysate-reactive material in hemodialysis. First-use syndrome.
    Pearson FC
    Blood Purif; 1987; 5(2-3):115-22. PubMed ID: 3620119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative importance of membrane Limulus amebocyte lysate-reactive material and ethylene oxide in hypersensitivity reactions.
    Pearson FC
    Contrib Nephrol; 1987; 59():134-44. PubMed ID: 3442983
    [No Abstract]   [Full Text] [Related]  

  • 3. Limulus amebocyte lysate reactivity, complement activation, and patients' symptoms. Comparison of dialyzer membranes.
    Moss AH; Hamrick RM; Shen SH
    ASAIO Trans; 1989; 35(4):812-5. PubMed ID: 2611049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anaphylactoid reactions during haemodialysis are due to ethylene oxide hypersensitivity.
    Nicholls AJ; Platts MM
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():173-7. PubMed ID: 3991498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypersensitivity reactions during haemodialysis: role of complement fragments and ethylene oxide antibodies.
    Lemke HD; Heidland A; Schaefer RM
    Nephrol Dial Transplant; 1990; 5(4):264-9. PubMed ID: 2113222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of the Limulus amebocyte lysate assay to monitor hemodialyzer-associated soluble cellulosic material (LAL-reactive material).
    Pearson FC; Caruana R; Burkart J; Katz DV; Chenoweth D; Dubczak J; Bohon J; Weary M
    Prog Clin Biol Res; 1987; 231():211-22. PubMed ID: 3588619
    [No Abstract]   [Full Text] [Related]  

  • 7. IgE against ethylene oxide-altered human serum albumin (ETO-HSA) as an etiologic agent in allergic reactions of hemodialysis patients.
    Grammer LC; Patterson R
    Artif Organs; 1987 Apr; 11(2):97-9. PubMed ID: 3593052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is contact activation of the coagulation system involved in the genesis of the first-use syndrome?
    Vaziri ND
    Artif Organs; 1987 Apr; 11(2):163-4. PubMed ID: 3496073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type I allergy induced by Limulus Amoebocyte Lysate (LAL).
    Ebner C; Kraft D; Prasch F; Steiner R; Ebner H
    Clin Exp Allergy; 1992 Mar; 22(3):417-9. PubMed ID: 1586879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study on limulus amebocyte lysate (LAL) reactive material derived from dialyzers.
    Yoshioka T; Ikegami K; Ikemura K; Shiono S; Uenishi M; Sugimoto H; Sugimoto T
    Jpn J Surg; 1989 Jan; 19(1):38-41. PubMed ID: 2733277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hollow-fiber dialyzers and their pyrogenicity testing by Limulus amebocyte lysate.
    Henne W; Schulze H; Pelger M; Tretzel J; von Sengbusch G
    Artif Organs; 1984 Aug; 8(3):299-305. PubMed ID: 6477197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of endotoxin levels and their impact on interleukin-1 generation in continuous ambulatory peritoneal dialysis and hemodialysis.
    Pearson FC; Dubczak J; Weary M; Anderson J
    Blood Purif; 1988; 6(3):207-12. PubMed ID: 3293624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal study of specific IgE and IgG antibodies in a patient sensitized to ethylene oxide through dialysis.
    Wass U; Belin L; Delin K
    J Allergy Clin Immunol; 1988 Oct; 82(4):679-85. PubMed ID: 3171008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of chemical analyses of hollow-fiber dialyzer extracts.
    Pearson FC; Bohon J; Lee W; Bruszer G; Sagona M; Dawe R; Jakubowski G; Morrison D; Dinarello C
    Artif Organs; 1984 Aug; 8(3):291-8. PubMed ID: 6383298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethylene oxide and hypersensitivity reactions in patients on hemodialysis.
    Röckel A; Hertel J; Wahn U; Perschel WT; Thiel C; Abdelhamid S; Fiegel P; Walb D
    Kidney Int Suppl; 1988 Mar; 24():S62-7. PubMed ID: 3163054
    [No Abstract]   [Full Text] [Related]  

  • 16. Ethylene-oxide-induced IgE antibodies and symptomatology in dialysis patients.
    Rumpf KW; Seubert S; Seubert A; Jaeger M; Lowitz HD; Valentin R; Schünemann B; Thon P; Tönnies HJ; Quellhorst E
    Contrib Nephrol; 1987; 59():145-53. PubMed ID: 3442984
    [No Abstract]   [Full Text] [Related]  

  • 17. Endotoxemia in patients on hemodialysis.
    Taniguchi T; Katsushima S; Lee K; Hidaka A; Konishi J; Ideguchi H; Kawaguchi Y
    Nephron; 1990; 56(1):44-9. PubMed ID: 2234248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of dialyzer contaminants in the allergic epiphenomena of hemodialysis.
    Ward RA; Feldhoff PW; Klein E
    Artif Organs; 1984 Aug; 8(3):338-49. PubMed ID: 6477203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of Limulus amebocyte lysate reactive material in capillary flow hemodialyzers.
    Pearson FC; Weary M; Bohon J
    Prog Clin Biol Res; 1982; 93():247-60. PubMed ID: 6289355
    [No Abstract]   [Full Text] [Related]  

  • 20. Mediation of hypersensitivity reactions during hemodialysis by IgE antibodies against ethylene oxide.
    Lemke HD
    Artif Organs; 1987 Apr; 11(2):104-10. PubMed ID: 3297007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.